Operating income increased 128.6%
Operating income changed +128.6% from the comparable as-filed period. The change ranks at the 79th percentile of 75 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +128.6% from the comparable as-filed period. The change ranks at the 79th percentile of 75 prior comparable changes.
Gross profit changed +20.4% from the comparable as-filed period. The change ranks at the 31th percentile of 75 prior comparable changes.
Net income changed +4659.4% from the comparable as-filed period. The change ranks at the 100th percentile of 85 prior comparable changes.
Revenue changed +22.0% from the comparable as-filed period. The change ranks at the 31th percentile of 75 prior comparable changes.
Cash & equivalents changed -15.1% from the comparable as-filed period. The change ranks at the 16th percentile of 136 prior comparable changes.
Operating margin changed +263 basis points from the comparable as-filed period. The change ranks at the 17th percentile of 75 prior comparable changes.
Research & development changed +12.2% from the comparable as-filed period. The change ranks at the 21th percentile of 75 prior comparable changes.
Debt changed +0.2% from the comparable as-filed period. The change ranks at the 85th percentile of 34 prior comparable changes.
Gross margin changed -65 basis points from the comparable as-filed period. The change ranks at the 19th percentile of 75 prior comparable changes.
Stock-based compensation changed -4.9% from the comparable as-filed period. The change ranks at the 8th percentile of 75 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.